Health tech naming sits at the intersection of three different credibility filters: the clinical register that hospital procurement committees apply, the technology register that CIOs and IT departments use, and the wellness register that consumer digital health platforms need to convert patients. A name that passes all three is rare. The companies that have built the most durable health tech franchises resolved this tension by choosing one register and executing it flawlessly rather than trying to satisfy all three.
Health tech companies divide across five architectures with substantially different buyers, regulatory frameworks, and naming constraints. The architecture must be clear before naming begins -- the FDA has different jurisdiction over a Software as a Medical Device than over a health analytics platform, and those regulatory differences cascade directly into naming requirements.
| Architecture | Primary Buyer | Naming Register | Key Constraint |
|---|---|---|---|
| EHR / EMR platform | CMIOs, CIOs, hospital administration | Clinical authority, institutional neutrality | ONC Health IT certification identity; HL7 FHIR implementation guide publisher name; CHPL listing permanence |
| Telehealth platform | Health system VPs, payer medical directors, consumers | Access and convenience (B2C); compliance and scale (B2B) | State telehealth licensure compact registration; state medical board platform approval identity; HIPAA BAA entity name |
| Software as a Medical Device (SaMD) | Clinicians, health systems, FDA clearance recipients | Clinical precision, safety-first, regulatory credibility | FDA 510(k) or De Novo submission identity; EU MDR Article 26 SaMD classification; CE mark technical file publisher |
| Health IT analytics / population health | Analytics teams, CMOs, value-based care program managers | Data intelligence, outcomes-oriented, neutral technology | CMS APM program participant identity; NCQA measure specifications publisher; state HIE data use agreement entity |
| Consumer digital health | Patients, employers, health plan members | Accessible, aspirational, behavior-change register | FTC health claim substantiation; app store medical category guidelines; employer benefit program approved vendor list identity |
Health IT products seeking ONC (Office of the National Coordinator) Health IT certification -- required for EHR products used in Meaningful Use, Promoting Interoperability, and MIPS programs -- are listed in the Certified Health IT Products List (CHPL) under the developer's legal entity name. This listing is a public record that hospital procurement teams, CMS auditors, and health IT analysts use as a primary verification tool.
ONC certification records include the developer name, product name, certification edition, and certification date. A company that renames must update its CHPL listing with ONC, which requires a change request through the ONC certification program. Historical certification records remain indexed under the original developer name -- creating a reference gap when procurement teams cross-reference CHPL against a vendor's current legal name. Several mid-size EHR vendors acquired by larger health IT companies have found that their CHPL histories index under three or four successive legal entity names, complicating provider due diligence on the product's certification continuity.
Companies publishing FHIR (Fast Healthcare Interoperability Resources) implementation guides through HL7 do so under a publisher name embedded in the guide itself. Implementation guides are versioned, widely referenced, and cached across health IT environments. The publisher name in an HL7 implementation guide is effectively permanent: downstream systems that reference the guide retain the publisher name in their documentation and integration specifications indefinitely.
For health IT vendors whose product architectures are defined by FHIR implementation guides they have published -- common in care coordination, prior authorization, and clinical decision support platforms -- the company name embedded in those guides represents a technical identity that is expensive to update across the installed base. Several companies have published guides under a product name rather than the corporate entity name specifically to insulate the guide's identity from corporate restructuring and rebranding.
Software as a Medical Device cleared through FDA's 510(k) pathway, approved through De Novo, or subject to PMA is submitted and cleared under the applicant's legal entity name. The FDA clearance letter, 510(k) summary, and product listing in FDA's CDRH database all use the applicant name at time of submission. The FDA Product Code database and the 510(k) database are public records used by clinical buyers, hospital value analysis committees (VACs), and payers to verify regulatory status.
A SaMD company that renames after receiving FDA clearance must notify FDA through a 510(k) supplement or change notification, depending on the nature of the change. During the review period, the FDA database continues to show the legacy company name -- which creates a mismatch between the company's current market identity and its regulatory clearance identity. Hospital VACs and health system legal departments conducting due diligence frequently flag this mismatch as a regulatory compliance concern that must be resolved before purchase order execution.
For companies seeking clearance in multiple international markets (EU MDR, Health Canada, PMDA in Japan), each jurisdiction has its own manufacturer registration database. A name change triggers parallel update filings across all jurisdictions, each with its own review timeline and potential gap period.
Health tech companies that handle protected health information (PHI) on behalf of covered entities must execute Business Associate Agreements (BAAs). The BAA is a legal contract that names the business associate -- it is often attached to master service agreements and may be renewed on multi-year cycles. A company name change requires BAA amendments with every covered entity customer, which may require their legal department review and signature processes.
For health tech companies with large provider or payer customer bases, BAA amendment at scale -- potentially hundreds of agreements -- is a significant operational project. Several health tech companies that went through PE-driven rebrands have found that BAA amendment was the single most time-consuming element of the rebrand, taking longer than technology migration, marketing updates, or regulatory filings.
There is also a subtler naming exposure: health tech company names that imply specific HIPAA-regulated activities -- "ClaimProcessor," "PatientData," "PHIVault" -- create elevated scrutiny from covered entity privacy officers reviewing BAAs. A name that signals the company handles sensitive data categories invites more detailed due diligence questionnaires and longer procurement cycles.
Consumer digital health companies face FTC health claim substantiation requirements that apply to company names as well as product claims. A company name that implies clinical effectiveness, diagnostic capability, or treatment outcomes -- "CurePath," "TreatWell," "DiagnosticAI" -- must be substantiated under the same FTC standards applied to advertising claims. The FTC's Digital Health Policy team has been active in this space, and the agency has brought enforcement actions against digital health companies whose marketing -- including names -- implied clinical benefits without adequate substantiation.
The FDA has parallel jurisdiction over consumer health tech products that make disease claims. A consumer app whose name implies it can diagnose, treat, or prevent a specific condition may require FDA clearance as a SaMD before the name can be used in commerce. The boundary between a wellness app and a medical device is increasingly defined by the claims implied in the product name and marketing, not just the technical function.
| Company | Architecture | Phoneme Profile | Naming Strategy |
|---|---|---|---|
| Epic Systems | EHR / health system platform | Common word; single syllable; aspirational scope; institutional | "Epic" signals scale and significance without clinical vocabulary -- appropriate for a platform that touches every aspect of hospital operations; "Systems" suffix grounds the aspiration with functional credibility; works across clinical, administrative, and patient-facing contexts |
| Cerner (now Oracle Health) | EHR / health IT platform | Coined; two syllables; technological register; neutral | Invented name with no clinical vocabulary -- appropriate for an IT company selling into healthcare rather than a clinical company; neutral institutional register works for hospital CIO buyers; Oracle acquisition retained "Health" as product brand while transitioning corporate identity |
| Veeva Systems | Life sciences / health tech SaaS | Coined; two syllables; soft opening; distinctive | Invented name with no pharmaceutical or healthcare vocabulary -- allows expansion from clinical trial management to commercial operations to quality without category limitation; "Systems" suffix adds enterprise credibility; strong trademark distinctiveness |
| Health Catalyst | Health IT analytics | Descriptive compound; health + catalyst metaphor; institutional | Transparent derivation signals the value proposition (catalyst for health system improvement) without clinical claim vocabulary; "catalyst" positions as enabling technology rather than clinical decision-making -- important for analytics platforms that must avoid SaMD classification |
| Teladoc Health | Telehealth | Tele- prefix + doc fragment; transparent derivation; accessible | "Tele" signals remote delivery; "doc" (doctor fragment) provides clinical credibility without credential claim; consumer-accessible register for patient-facing acquisition while maintaining clinical authority for health system B2B sales |
| Hims & Hers | Consumer digital health / telehealth | Pronoun pair; conversational, direct, gendered segmentation | First-person pronouns signal direct-to-consumer register and personal health focus; gendered naming creates immediate audience segmentation; conversational register intentionally distances from clinical authority -- positions as personal health brand rather than medical platform |
| Transcarent | Employer health benefits / navigation | Trans- (across) + parent/transparent morpheme; coined; three syllables | Morpheme blend suggests transparency across the healthcare navigation experience; "trans-" prefix signals cross-system navigation function; institutional register appropriate for employer HR and benefits buyer; avoids clinical vocabulary that would imply regulated medical function |
| Noom | Consumer digital health (weight management) | Coined; monosyllable; reversed "moon" morpheme; distinctive | Short, memorable, no health or wellness vocabulary -- designed for consumer app store discovery and word-of-mouth; deliberate distance from clinical register avoids FTC health claim scrutiny while the product itself navigates the wellness-to-medical boundary carefully |
"Epic" is the canonical example: a common English word repurposed as a company name, carrying no health vocabulary, signaling scale and significance. This profile works for enterprise health IT platforms that need to communicate ambition to health system leadership while remaining technically neutral for IT department evaluation. The single word is memorable, trademark-strong, and expands cleanly across products and markets.
"Cerner," "Veeva," "Zynx" -- invented names with no health vocabulary work well for health IT companies that started in one segment and expanded across multiple clinical and administrative markets. The invention avoids clinical claim exposure, provides trademark strength, and does not limit the company to any specific health category as it diversifies. This is the default profile for health IT platforms that anticipate significant product line expansion.
"Teladoc," "Transcarent," "Included Health" -- compounds using transparent morphemes that signal function without making clinical claims. "Tele" signals remote delivery; "trans" signals navigation; "included" signals access. These names communicate value proposition clearly to buyers without the FTC claim exposure of outcome vocabulary. They work best when the underlying function is genuinely novel and the name's job is to explain it.
"Noom," "Hims," "Ro," "Calm" -- consumer digital health companies that acquire patients directly through app stores and digital advertising need names that perform in consumer search, social sharing, and app discovery contexts. Short, distinctive, no clinical vocabulary. These names deliberately distance from medical register to avoid FTC scrutiny and to convert patients who are motivated by wellness aspiration rather than clinical need. The consumer register is a liability in enterprise health system sales, so this profile works only for companies committed to direct-to-consumer as their primary growth channel.
ONC CHPL certification records, FDA 510(k) clearance databases, HIPAA BAA portfolios, and state telehealth platform registrations collectively create one of the most complex regulatory name records of any technology sector. A health tech company that names poorly and must rebrand faces update requirements across federal health IT databases, FDA product listings, state medical board records, and hundreds of BAA agreements simultaneously. The naming decision at founding is a regulatory infrastructure decision, not just a marketing one.
Voxa runs phoneme analysis, FDA and FTC vocabulary screening, health IT category register mapping, trademark clearance, and domain availability in parallel -- then ranks candidates against your architecture, regulatory requirements, and buyer register.
Get Your Health Tech Company Name